PTC Therapeutics, Inc.
PTCT
$50.57
$1.653.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.85M | 866.56M | -65.89M | -106.65M | -99.18M |
| Total Depreciation and Amortization | 7.58M | 7.22M | 6.76M | 6.49M | 7.02M |
| Total Amortization of Deferred Charges | 302.00K | 299.00K | 307.00K | 300.00K | 295.00K |
| Total Other Non-Cash Items | 15.35M | 38.10M | -7.77M | 13.04M | 31.59M |
| Change in Net Operating Assets | -16.72M | -42.08M | 36.58M | 9.83M | -11.18M |
| Cash from Operations | -58.33M | 870.10M | -30.00M | -76.99M | -71.45M |
| Capital Expenditure | -1.32M | -1.72M | -3.77M | -522.00K | 7.38M |
| Sale of Property, Plant, and Equipment | 0.00 | 70.00K | 0.00 | 18.00K | 28.04M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -420.69M | -182.71M | 271.48M | -42.17M | -101.34M |
| Cash from Investing | -422.01M | -184.36M | 267.71M | -42.68M | -65.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 3.96M | 15.75M | 26.47M | 573.00K | 4.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -6.34M | 0.00 | -18.20M | 241.79M |
| Cash from Financing | 3.96M | 9.41M | 26.47M | -17.63M | 246.48M |
| Foreign Exchange rate Adjustments | 13.59M | 5.39M | -8.65M | 8.54M | -5.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -462.79M | 700.55M | 255.53M | -128.75M | 103.92M |